Dow Up 0.66% Nasdaq Up 0.88%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
17.92 Up 3.73(26.29%) 4:00PM EDT
|After Hours : 17.29 Down 0.63 (3.52%) 6:33PM EDT - Nasdaq Real Time Price
Prev Close:14.19
Open:14.83
Bid:17.27 x 300
Ask:17.29 x 200
1y Target Est:18.73
Beta:1.21751
Earnings Date:May 5 - May 9 (Est.)
Day's Range:14.52 - 18.14
52wk Range:8.00 - 41.97
Volume:21,834,407
Avg Vol (3m):4,428,040
Market Cap:818.34M
P/E (ttm):N/A
EPS (ttm):-5.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
SRPTUp 26.29%818.34M
GSKUp 0.89%104.76B
ALNYUp 2.61%5.87B
ISIS 0.00%6.91B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):517.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-4.34
Quarterly EPS Est (Mar-16) :-1.30
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):16.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback